Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics
Cancer Science · 2024
DOI: 10.1111/cas.16364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Kuo-Ting Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Linkage Disequilibrium, Polymorphism, Single Nucleotide, Breast Neoplasms, BRCA2 Protein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: E-Da Hospital, Chi Mei Medical Center, National Cheng Kung University Hospital.
Abstract (Originalsprache)
Germline pathogenic mutation of the BRCA gene increases the prevalence of breast cancer. Reports on the benign variants of BRCA genes are limited. However, the definition of these variants might be altered with the accumulation of clinical evidence. Therefore, in the present study, we focused on benign single nucleotide polymorphisms (SNPs) of BRCA genes. Linkage disequilibrium was calculated from whole genome sequencing of the BRCA genes obtained from 500 healthy controls and 49 breast cancer patients. Sanger sequencing was used to confirm the mutation. The linkage disequilibrium was noted for seven and three SNPs in the BRCA1 and BRCA2 genes, respectively. Breast cancer with BRCA1 / 2 linkage disequilibrium was not correlated with a personal history of benign diseases or family history of cancer. Nevertheless, breast cancer with BRCA1 linkage disequilibrium was correlated with high tumor‐infiltrating lymphocytes and positive extensive intraductal components. The patients with BRCA1 linkage disequilibrium tended to have worse disease‐specific survival. Cancers with BRCA2 linkage disequilibrium are associated with a lower ratio of grade III cancer. Moreover, patients with BRCA2 linkage disequilibrium tended to have better overall survival. In conclusion, linkage disequilibrium from benign SNPs of the BRCA genes potentially affects cancer characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Kim Forest Enterprise Co., Ltd., New Taipei, Taiwan.
- Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
- Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Hui-Ping Hsu
Förderung
- E-Da Hospital
- Chi Mei Medical Center
- National Cheng Kung University Hospital
- Ministry of Science and Technology, Taiwan
- National Science and Technology Council
Zitieren
APA
Lee, K. T., Chen, D. P., Loh, Z. J., Chung, W. P., Wang, C. Y., Chen, P. S., Cheung, C. H. A., Chang, C. P., & Hsu, H. P. (2024). Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics. Cancer Science. https://doi.org/10.1111/cas.16364
Vancouver
Lee KT, Chen DP, Loh ZJ, Chung WP, Wang CY, Chen PS, et al. Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics. Cancer Science. 2024. doi:10.1111/cas.16364
BibTeX
@article{Lee2024,
author = {Lee, Kuo-Ting and Chen, Dao-Peng and Loh, Zhu-Jun and Chung, Wei-Pang and Wang, Chih-Yang and Chen, Pai-Sheng and Cheung, Chun Hei Antonio and Chang, Chih-Peng and Hsu, Hui-Ping},
title = {Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16364}
}
EUVIMED